Consumers can advance a lawsuit alleging Splenda maker TC Heartland LLC deceptively advertised products with “diabetes care” statements, because their claims aren’t preempted by federal regulations, a judge said.
The US District Court for the Northern District of California on Thursday said the claims aren’t preempted because the consumers allege TC Heartland’s label statements go beyond the Food and Drug Administration’s safety determination.
The consumers brought their proposed class action in August 2023, a few months after the World Health Organization advised against using non-sugar sweeteners. WHO’s recommendation stated long-term use of these sugar alternatives could increase the risk of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.